Leading Korean CRO Strengthens Global R&D Capabilities By Expanding Use Of Medidata Solutions, Inc.’s Cloud Technology Platform

LSK Global PS Adopts Medidata’s Clinical Trial Management Solution for Worldwide Operational Efficiency and Project Oversight

NEW YORK & SEOUL, Korea--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, and LSK Global Pharma Services (“LSK Global PS”), a leading contract research organization (CRO) in South Korea, today announced that LSK Global PS has expanded its use of the Medidata Clinical Cloud^® platform. The Seoul-based organization is the first Korean company to prioritize its global operational efficiencies and decision-making processes by implementing Medidata CTMS^®—further demonstrating its traction in the growing Asia-Pacific market and beyond.

“LSK Global PS is dedicated to advancing the quality of our domestic clinical trials to that of a global standard, and Medidata’s robust, globally-validated CTMS is helping us reach that standard”

“LSK Global PS is dedicated to advancing the quality of our domestic clinical trials to that of a global standard, and Medidata’s robust, globally-validated CTMS is helping us reach that standard,” said Young Jack Lee, president of LSK Global PS.

“Medidata CTMS enables us to conduct more efficient clinical research, accelerating study timelines and reducing development costs while ensuring the highest quality. We’re excited to take our drug development program to the next level by using more technology solutions on Medidata’s industry-leading, unified cloud platform to manage clinical trials across therapeutic areas,” Lee added.

Established in 2000, LSK Global PS is a full-service CRO conducting hundreds of clinical trial programs on both a local and global scale. Specializing in a number of therapeutic areas—including oncology, cardiovascular and endocrinology, among others—LSK Global PS conducts Phase I-Phase IV studies, investigator initiated trials, post-market surveillance (PMS), and observational research, and provides data management services for its life sciences customers.

LSK Global PS has been utilizing Medidata’s electronic data capture, management and reporting tool (Medidata Rave^®), medical coding solution (Medidata Coder^®), and unified randomization and trial supply management solution (Medidata Balance^®). To provide better oversight into trial operations and streamline its site monitoring processes, the CRO is now adopting Medidata’s clinical trial management system, Medidata CTMS.

“As South Korea continues to evolve as a key market in Asia’s expanding clinical trial landscape, we’re pleased to be strengthening our partnership with LSK Global PS,” said Edwin Ng, Medidata’s vice president of field operations, APeJ (Asia Pacific except Japan). “By leveraging CTMS’ customized reporting capabilities—powered by its seamless integration with Rave—LSK Global PS is able to extract the operational data it needs to effectively deploy critical resources, proactively address performance issues and streamline study workflows. We look forward to our ongoing collaboration with LSK, providing its research teams with the technology needed to accelerate medical innovation across the region and beyond.”

Connect with Medidata

• Read our blog, Geeks Talk Clinical
• Tweet this: LSK Global becomes 1st #Korean CRO to adopt @Medidata #clinicaltrial mgmt solution to improve study operations http://ow.ly/2d3t301dLSY #tech
• Follow us on Twitter: @Medidata
• Find us on LinkedIn

About LSK Global Pharma Services

LSK Global Pharma Services is a full-service contract research organization (CRO), established in 2000. Specializing in a number of therapeutic areas including oncology, cardiovascular and endocrinology, among others, LSK Global PS conducts Phase I-Phase IV studies, investigator initiated trials, post-market surveillance (PMS), and observational research for its life sciences customers.

About Medidata

Medidata is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. We are committed to advancing the competitive and scientific goals of our life sciences customers worldwide: more than 600 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations. Our industry-leading technology platform, the Medidata Clinical Cloud®, is the primary technology solution powering clinical trials for 17 of the world's top 25 global pharmaceutical companies, bringing new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting.